Ganciclovir (injection): Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ganciclovir}} | |||
{{CMG}} | |||
==Overview== | |||
'''Ganciclovir''' [[International Nonproprietary Name|INN]] {{IPAc-en|ɡ|æ|n|ˈ|s|aɪ|k|l|ə|v|ɪər}} or '''DHPG''' (9-(1,3-dihydroxy-2-propoxymethyl)guanine) is an [[antiviral medication]] used to treat or prevent [[cytomegalovirus]] (CMV) infections. '''Ganciclovir sodium''' is marketed under the trade names '''Cytovene''' and '''Cymevene''' ([[Hoffman-La Roche|Roche]]). Ganciclovir for ocular use is marketed under the trade name '''Vitrasert''' ([[Bausch & Lomb]]). A prodrug form with improved oral [[bioavailability]] ([[valganciclovir]]) has also been developed. | |||
==Category== | |||
Antiviral | |||
==US Brand Names== | |||
VITRASERT<sup>®</sup> | |||
==FDA Package Insert== | |||
''' [[Ganciclovir description|Description]]''' | |||
'''| [[Ganciclovir clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Ganciclovir microbiology|Microbiology]]''' | |||
'''| [[Ganciclovir indications and usage|Indications and Usage]]''' | |||
'''| [[Ganciclovir contraindications|Contraindications]]''' | |||
'''| [[Ganciclovir warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Ganciclovir adverse reactions|Adverse Reactions]]''' | |||
'''| [[Ganciclovir drug interactions|Drug Interactions]]''' | |||
'''| [[Ganciclovir overdosage|Overdosage]]''' | |||
'''| [[Ganciclovir clinical studies|Clinical Studies]]''' | |||
'''| [[Ganciclovir dosage and administration|Dosage and Administration]]''' | |||
'''| [[Ganciclovir how supplied|How Supplied]]''' | |||
'''| [[Ganciclovir labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Revision as of 22:02, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ganciclovir INN /ɡænˈsaɪkləvɪər/ or DHPG (9-(1,3-dihydroxy-2-propoxymethyl)guanine) is an antiviral medication used to treat or prevent cytomegalovirus (CMV) infections. Ganciclovir sodium is marketed under the trade names Cytovene and Cymevene (Roche). Ganciclovir for ocular use is marketed under the trade name Vitrasert (Bausch & Lomb). A prodrug form with improved oral bioavailability (valganciclovir) has also been developed.
Category
Antiviral
US Brand Names
VITRASERT®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages